Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Neurology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... unprecedented event that has impacted nearly every healthcare business around the world. The COVID-19 disease affects older people as well as people with underlying comorbidities. Neurological diseases are a common cause of mortality rate in ... Read More
-
Pigmentation Disorders Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 pandemic has impacted the pigmentation disorder treatment market. Hamilton Fraser Cosmetic Insurance surveyed approximately 1,360 cosmetic surgeons in the United Kingdom in March 2020 to determine the pandemic's effects. The survey found that 99.78% ... Read More
-
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hemophilia B (Factor IX Deficiency) Clinical trials scenario. This report provides ... Read More
-
Alzheimer’s Disease Therapeutics (2022 Edition) – Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)
... Analysis has 101 active drugs undergoing several stages of clinical trials. The Alzheimer’s disease Therapeutics Pipeline is driven by an increasing gap of unmet need of effective therapeutics that can cure Alzheimer’s disease. Additionally, life ... Read More
-
Polycystic Ovarian Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2022-2027. The outbreak of COVID-19 had a significant impact on the healthcare industry. The polycystic ovarian syndrome (PCOS) treatment market is not immune to the effects of the pandemic, which had ramifications for many surgical ... Read More
-
In Silico Clinical Trials Market- Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... spread of COVID-19 significantly influences the in silico clinical trials market. Even though the news article "Why 2020 Saw The Steady Rise Of In Silico Trials", published in January 2021, explains that as COVID-19-related constraints ... Read More
-
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... is the known receptor for nitric oxide. Binding of nitric oxide to the heme moiety of the cyclase induces its capacity to synthesize the second messenger cGMP. Although the changes in the state of the ... Read More
-
Liver Failure (Hepatic Insufficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Liver Failure (Hepatic Insufficiency) Clinical trials scenario. This report provides top line data ... Read More
-
Clinical Trial Management Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 pandemic affected the clinical research activities as a large number of clinical studies on other diseases around the world were disrupted by the pandemic and the companies shifted their focus to the development of ... Read More
-
Autism Spectrum Disorder Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
... is a highly heterogenous disorder characterized by varying social and communication impairments and pervasive repetitive behaviors, in addition to a wide range of associated non-core symptoms. The ASD market is chronically underserved, with no approved ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 440,000 diagnosed prevalent cases of esophageal cancer across 16 pharmaceutical markets. Currently there are four leading marketed innovator drugs for the treatment of esophageal cancer, mostly programmed cell death protein 1 (PD1) ... Read More
-
Global Oncolytic Virus Therapy Market - 2022-2029
... naturally occurring virus that can imitate selected terms and kill cancer cells without harming normal tissues. Oncolytic Virus therapy is a new therapeutic approach for treating cancer and has shown promising results globally. Market Dynamics ... Read More
-
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases (I to IV), Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs) - Global Forecast 2027
... Trial Supplies market is projected to reach USD 5.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 9.7% during the forecast period of 2022 to 2027. Factors such a as ... Read More
-
Clinical Trials Support Service Market Growth Forecast Analysis Report 2030
... restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical Trials Support Service market size is ... Read More
-
Clinical Trials Outsourcing Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical Trials Outsourcing market size is growing at ... Read More
-
Global Nasopharyngeal Cancer Market - 2022-2029
... % during the forecast period (2022-2029). Nasopharyngeal cancer is a rare therapy of malignant cancer that appears in the nasopharynx. It is the upper part of the throat behind the nose. The nasopharynx is situated ... Read More
-
Global Bronchiectasis Treatment Market - 2022-2029
... 6.0% during the forecast period (2022-2029). Bronchiectasis is a condition affecting the airways in the lungs that causes cough, increased mucus production, and recurrent lung infections. The symptoms are caused by abnormal widening of the ... Read More
-
Global Phenylketonuria Treatment Market - 2022-2029
... accumulates the amino acid phenylalanine. PKU is caused by a mutation in a gene that aids in the production of the phenylalanine-degrading enzyme. Seizures, mental illnesses, and other untreated disorders can result from an excess ... Read More
-
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 10.7 million diagnosed prevalent cases of axSpA across 16 pharmaceutical markets. Currently there are eight leading marketed drugs for the treatment of axSpA, and AbbVie is a key player in the disease ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
... these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug ... Read More
-
Clinical Trials Management System Market Research Report 2022-2030
... trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Clinical ... Read More
-
Artificial Intelligence Based Clinical Trials Solution Provider Market Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030
... data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
-
Global Glioblastoma Multiforme Market - 2022-2029
... nervous system tumor. Globally, GBM accounts for 54% of new gliomas and 45% of primary malignant tumors. GBM can be either intra tentorial (area located below tentorium cerebella) or supratentorial (area located above the tentorium ... Read More
-
Global Neuroendocrine Cancer Market - 2022-2029
... during the forecast period (2022-2029). Neuroendocrine tumors are tumors that start in specialized neuroendocrine cells. Nerve cells and hormone-producing cells share characteristics with neuroendocrine cells. Market Dynamics The increasing research and development and the growing ... Read More
Research Assistance
